All Curated Mutation Sites in HPV

The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in HPV related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.

Browse Data by Virus Gene/Protein/Region, Disease OR Description

*Please select one option you are interested in, the page will be automatically redirected.

Virus Gene/Protein

Disease

Description

Click the button below to quickly view the viral genes/regions/protein for mutation

Show All

E1^E4

Keyword: Cervical Intraepithelial Neoplasia-30471332

ID	PMID	Mutation	Gene/Protein/Region	Encoding Gene/Protein	Disease	Description	Detail
1	30471332	A763G	E7	E7	Cervical Intraepithelial Neoplasia	G R S C L	View
2	30471332	C632T	E7	E7	Cervical Intraepithelial Neoplasia	G R S C L	View
3	30471332	C755A	E7	E7	Cervical Intraepithelial Neoplasia	G R S C L	View
4	30471332	D35E	E7	E7	Cervical Intraepithelial Neoplasia	G R S C L	View
5	30471332	G41R	E7	E7	Cervical Intraepithelial Neoplasia	G R S C L	View
6	30471332	G599A	E7	E7	Cervical Intraepithelial Neoplasia	G R S C L	View
7	30471332	G63D	E7	E7	Cervical Intraepithelial Neoplasia	G R S C L	View
8	30471332	G63S	E7	E7	Cervical Intraepithelial Neoplasia	G R S C L	View
9	30471332	G694A	E7	E7	Cervical Intraepithelial Neoplasia	G R S C L	View
10	30471332	G760A	E7	E7	Cervical Intraepithelial Neoplasia	G R S C L	View
11	30471332	G761A	E7	E7	Cervical Intraepithelial Neoplasia	G R S C L	View
12	30471332	R9K	E7	E7	Cervical Intraepithelial Neoplasia	G R S C L	View
13	30471332	T20I	E7	E7	Cervical Intraepithelial Neoplasia	G R S C L	View
14	30471332	T61N	E7	E7	Cervical Intraepithelial Neoplasia	G R S C L	View
15	30471332	T64A	E7	E7	Cervical Intraepithelial Neoplasia	G R S C L	View
16	30471332	T678A	E7	E7	Cervical Intraepithelial Neoplasia	G R S C L	View
17	30471332	T726C	E7	E7	Cervical Intraepithelial Neoplasia	G R S C L	View
18	30471332	T744G	E7	E7	Cervical Intraepithelial Neoplasia	G R S C L	View
19	30471332	T756C	E7	E7	Cervical Intraepithelial Neoplasia	G R S C L	View
20	30471332	T803C	E7	E7	Cervical Intraepithelial Neoplasia	G R S C L	View
21	30471332	V77A	E7	E7	Cervical Intraepithelial Neoplasia	G R S C L	View
22	30471332	A194C	E6	E6	Cervical Intraepithelial Neoplasia	G R S C L	View
23	30471332	A259G	E6	E6	Cervical Intraepithelial Neoplasia	G R S C L	View
24	30471332	A260C	E6	E6	Cervical Intraepithelial Neoplasia	G R S C L	View
25	30471332	A388C	E6	E6	Cervical Intraepithelial Neoplasia	G R S C L	View
26	30471332	A390C	E6	E6	Cervical Intraepithelial Neoplasia	G R S C L	View
27	30471332	C187T	E6	E6	Cervical Intraepithelial Neoplasia	G R S C L	View
28	30471332	C228T	E6	E6	Cervical Intraepithelial Neoplasia	G R S C L	View
29	30471332	C307T	E6	E6	Cervical Intraepithelial Neoplasia	G R S C L	View
30	30471332	C534A	E6	E6	Cervical Intraepithelial Neoplasia	G R S C L	View
31	30471332	G145A	E6	E6	Cervical Intraepithelial Neoplasia	G R S C L	View
32	30471332	G225A	E6	E6	Cervical Intraepithelial Neoplasia	G R S C L	View
33	30471332	G432A	E6	E6	Cervical Intraepithelial Neoplasia	G R S C L	View
34	30471332	K29Q	E6	E6	Cervical Intraepithelial Neoplasia	G R S C L	View
35	30471332	K93N	E6	E6	Cervical Intraepithelial Neoplasia	G R S C L	View
36	30471332	K94T	E6	E6	Cervical Intraepithelial Neoplasia	G R S C L	View
37	30471332	P142H	E6	E6	Cervical Intraepithelial Neoplasia	G R S C L	View
38	30471332	R108K	E6	E6	Cervical Intraepithelial Neoplasia	G R S C L	View
39	30471332	R39Q	E6	E6	Cervical Intraepithelial Neoplasia	G R S C L	View
40	30471332	S40F	E6	E6	Cervical Intraepithelial Neoplasia	G R S C L	View
41	30471332	T152C	E6	E6	Cervical Intraepithelial Neoplasia	G R S C L	View
42	30471332	T217A	E6	E6	Cervical Intraepithelial Neoplasia	G R S C L	View

Contents
Description

The table shows all curated mutation sites of HPV in each literature

Table Description Column Note

D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.

G
The study mentioned the virus genotype/subtype information.

R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.

S
The study provided sequence information or accession numbers.

L
The study provided the geographic region/country of data origin.

C
The study provided clinical baseline information.

I
The study involved information related to immune.

T
The study involved host target genes.